Full vial shown · package appearance may vary by batch24/7 Customer Support
Lab tested for purity & quality
Ships from Canada within 24 hours
At Puffin Peptides, we work with an established Canadian manufacturer and handle packaging and fulfilment here in Canada. Keeping the process close to home gives us better visibility into quality, consistency, packaging, and the batches moving through our catalogue.
That means clearer product information, accessible batch documentation, responsive local support, and a more dependable ordering experience from checkout to delivery.
Our focus is simple: well-made research products, straightforward information, and reliable Canadian service.
Two powerful appetite pathways, one advanced approach: CagriSema combines cagrilintide and semaglutide to help you feel fuller sooner, stay satisfied longer, and naturally reduce food intake. By working with the body’s hunger and metabolic signals, it is designed to support meaningful weight loss and stronger blood-sugar control.
CAGRISEMA is supplied as 5 mg + 5 mg of lyophilized powder in a sealed glass vial for laboratory research. Confirm the selected vial and batch details before preparation.
CagriSema combines two chemically distinct compounds: cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist. The combination has no single CAS number, molecular formula or molecular weight.
This variant contains more than one compound, so a single mg-to-units preset does not apply.
Store unprepared vials in a cool, dry place away from heat and moisture.
Refrigerate prepared vials between 2–8°C.
Avoid repeated freeze-thaw cycles.
A clear, quick look at what CAGRISEMA is, how it works, and why it is being studied.
CagriSema is built around hunger, fullness, and weight management. It combines two different appetite signals so smaller meals may feel more satisfying and that full feeling may last longer.
CagriSema combines semaglutide, a GLP-1 receptor agonist, with cagrilintide, a long-acting amylin analogue. Randomized clinical development has focused on body weight and metabolic outcomes in overweight/obesity. [1]
Semaglutide brings GLP-1; Cagrilintide adds an amylin-like fullness signal. Think of one helping you reach ‘I’m full’ and the other helping that message feel harder to ignore.
The rationale is complementary satiety biology: GLP-1 and amylin signalling affect appetite and meal-related responses through different pathways. Combination efficacy must still be established empirically rather than assumed from mechanism. [1]
It may mean reaching the end of a smaller meal and actually feeling done. The goal is fewer battles with second portions, late-night snacks, and hunger returning too quickly.
Clinical trials measure body weight, waist circumference, glycemic markers and safety more reliably than subjective descriptions of being “done” after a meal. The latter should remain explanatory language rather than a guaranteed experience. [1]
That is a big part of the interest. Two complementary fullness signals may make food feel less demanding, allowing meals to become part of the day instead of the main thing on your mind.
“Food noise” is not a standardized indication. CagriSema’s clinical evidence is stronger for weight and metabolic endpoints than for that specific subjective construct. [1]
Semaglutide uses one GLP-1 pathway. CagriSema adds Cagrilintide, giving the combination another route for strengthening fullness and appetite control.
Semaglutide targets GLP-1R; CagriSema adds long-acting amylin-receptor activity through cagrilintide. That creates a two-compound, two-pathway strategy rather than a higher-strength version of semaglutide. [1]
CagriSema combines two separate compounds focused heavily on fullness. Tirzepatide is one molecule using GLP-1 and GIP. Similar goal, different tools.
CagriSema combines separate GLP-1 and amylin-based compounds; tirzepatide is one molecule with dual GIP/GLP-1 receptor agonism. Similar commercial themes do not mean identical pharmacology. [1]
Its main story is appetite and fullness. Retatrutide adds a glucagon signal connected to energy use, while CagriSema doubles down on helping the body and brain recognize that enough food has been eaten.
CagriSema’s rationale is dominated by GLP-1/amylin appetite and satiety biology, whereas retatrutide adds glucagon-receptor agonism. The mechanisms and development programs should not be treated as interchangeable. [1]
Because hunger can come from more than one signal. CagriSema addresses appetite from two directions, creating the possibility that eating less could feel easier than relying on one fullness pathway alone.
Interest comes from combining two clinically relevant appetite/satiety pathways and from randomized weight-management results. Long-term comparative evidence continues to develop. [1]
This product is offered for laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement or substitute for an approved product.
Confirm the selected vial and BAC-water amount, then enter the selected amount from the combined blend.
The selected strength automatically opens with the easy starting rule of 1 mg = 10 units.
CAGRISEMA · 5 mg + 5 mg selected · 10 mg combined
Easy rule: 1 mg = 10 units · Every 10 units = 1 mg
This calculator converts the values entered. It does not choose an amount.
This 10 mg combined-content vial opens with 1 mL of BAC water, creating the easy starting rule of 1 mg = 10 units.
If the water amount is changed above, use the updated easy rule shown by the calculator.
Do not shake the vialSlowly add the water down the inside wall of the vial, then gently swirl until fully dissolved.
Prepared vialsRefrigerate at 2–8°C
Unprepared vialsKeep cool and dry, away from heat, moisture, and direct sunlight
Every order is prepared and packed in Canada with care, accuracy, and attention to detail. In-stock orders are checked and packed within 24 hours, then shipped with Canada Post. Tracking is sent after the parcel’s first carrier scan.
2 customer reviews
Reviews are checked before publication. Your email is never displayed.
Nice site and helpful chat bot. I’ll be back again.
I can’t believe it but I’ve lost 30lb. It’s been 3 months and felt compelled to write a review. I know it’s not Puffin I have to thank but their site came up in google and brought me here. Thank youuuuuu! <3
Products in the same research area, each with its own pathway, evidence level and selectable strengths.
16% off
15% offPuffin Pick
15% offBest seller
Only logged in customers who have purchased this product may leave a review.
Hi! I’m Ask Puffin. I can explain peptides in plain language and help with products, prices, stock, shipping, and site questions. What can I help with?
Reviews
There are no reviews yet.